Abacus Medicine Group

Abacus Medicine Group company information, Employees & Contact Information

Even the best medicine in the world won’t work if it never reaches the patient, and insufficient access is a large and growing problem. The Abacus Medicine Group offers a range of different solutions and services that provide better access to life-critical medicine at affordable prices to millions of patients across the world. Our business purpose holds a substantial positive impact on healthcare systems and society and is something we're proud of. The company was founded in 2004 by CEO Flemming Wagner and Medical Director John Wagner and has experienced significant growth ever since. Today, we are more than 1,300 colleagues moving healthcare in Europe and beyond. The Abacus Medicine Group is among the 100 largest Danish companies. The Group operates as four brands: Abacus Medicine, Pluripharm, Abacus Medicine Pharma Services and Originalis. Learn more about the Abacus Medicine Group on our website below.

Company Details

Employees
914
Address
Kalvebod Brygge 35, København,hovedstaden 1560,denmark
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
København, Hovedstaden
Looking for a particular Abacus Medicine Group employee's phone or email?

Abacus Medicine Group Questions

News

Abacus Medicine to supply UK pharmacies after Chemilines agreement - The Pharmaceutical Journal

Abacus Medicine to supply UK pharmacies after Chemilines agreement The Pharmaceutical Journal

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux - Pharmaceutical Technology

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux Pharmaceutical Technology

Abacus Medicine - The Pharma Letter

Abacus Medicine The Pharma Letter

Belgium: Abacus Medicine acquiring A.forall’s R&H division - Investors in Healthcare

Belgium: Abacus Medicine acquiring A.forall’s R&H division Investors in Healthcare

Abacus Medicine Group appoints two new directors - medwatch.com

Abacus Medicine Group appoints two new directors medwatch.com

Abacus Medicine postpones IPO - European Biotechnology Magazine

Abacus Medicine postpones IPO European Biotechnology Magazine

Switzerland: Abacus Medicine Group acquires Swiss Cardio Technologies - Investors in Healthcare

Switzerland: Abacus Medicine Group acquires Swiss Cardio Technologies Investors in Healthcare

Abacus Medicine to acquire Pluripharm - The Pharma Letter

Abacus Medicine to acquire Pluripharm The Pharma Letter

Top Abacus Medicine Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant